This study aimed to examine miR-140 expression in clinical samples from tuberculosis 
| INTRODUC TI ON

Tuberculosis (TB) is a serious infectious disease and is caused by
Mycobacterium tuberculosis (M tb) infection, and TB has imposed great threats to human health worldwide.
1 According to the epidemic statistics, around 9 million individuals were diagnosed as TB patients, and TB caused around 1 million deaths in 2016. 2 In
China, owing to the spread of TB with drug resistance and the dual infection of TB and human immunodeficiency virus, the cases of TB infection have remarkably increased in recent years. 3 Mechanistic studies have shown that M tb is an intracellular pathogen, which can parasitize the host's macrophages, 4 and the elimination of mycobacteria by macrophages can be achieved through different mechanisms including regulating inflammatory responses, modulating host cell-death programs and regulating phagosome acidification and maturation. 5 Unfortunately, M tb can still survive and replicate via overcoming the microbicidal mechanisms of macrophages. In this regard, it is necessary for us to explore the molecular mechanisms underlying the immunological role of macrophages in M tb infection, which may provide us with new strategy for treatment of TB.
MiRNAs belong to a class of small, non-coding RNAs with [21] [22] [23] nt and can regulate gene expression at the post-translational level. biomarkers. 12 Liu et al, showed that TB induced miR-582-5p up-regulation in TB patients and miR-582-5p inhibited monocytes apoptosis by targeting forkhead box protein O1. 13 In addition, miR-223 was found to exert positive effect on the recruitment of lung neutrophil, which may be related to TB susceptibility, 14 and miR-124 could negatively regulate toll-like receptor signalling in M tb-infected alveolar macrophages. 15 Recently, studies from Lin et al, demonstrated that miR-140 was overexpressed in human macrophages infected with M tb using microarray analysis, 16 suggesting the potential actions of miR-140 in TB. Unfortunately, the role of miR-140 in TB has not been examined in detail so far.
In our current investigations, miR-140 up-regulation was found in the human peripheral blood mononuclear cells (PBMCs) from patients with TB, and further in vitro functional assays were performed to determine the miR-140 actions on the M tb survival and the proinflammatory cytokine levels in the human macrophages with M tb infection. In addition, the underlying molecular mechanisms were also assessed by the in vitro functional assays. The current investigations may imply the novel role of miR-140 in the host-bacterial interactions during M tb infections. 
| MATERIAL S AND ME THODS
| Clinical sample collection
| Cell lines and culture
Two human macrophage cell lines (THP-1 and U937) were commercially purchased from the ATCC company (Manassas, VA 
| MiRNA oligonucleotides, vectors and oligonucleotides transfection
The miRNA oligonucleotides including the mimic and inhibitor for miR-140 as well as their corresponding negative controls (NCs, the corresponding miRNAs with the scrambled sequence) were com- 
| M tb survival as determined by colony-forming unit assay
Mycobacterium tuberculosis survival after infecting into THP-1 or U937 cells was assessed by the colony-forming unit (CFU) assay.
Briefly, the transfected human macrophages were infected by M tb at 10 MOI for a duration of 48 hours followed by lysing the infected cells with sterile distilled water. Ten-fold serial dilutions were used for quantitative culturing with each dilution inoculated on Middlebrook 7H10 agar plates containing 10% oleic acid albumin dextrose catalase enrichment (Sigma). The M tb was cultured for 3 weeks at 37°C and the CFUs were determined using the standard protocols.
| Protein levels as determined by ELISA assay
The medium for culturing THP-1 and U937 cells that received different treatments was collected for the ELISA analysis of pro-inflammatory cytokine levels. The protein levels of interleukin 6 (IL-6), tumour necrosis-α (TNF-α), interleukin-1β (IL-1β) and interferon-γ (IFN-γ)
were analysed using the corresponding ELISA kits (Thermo Fisher Scientific).
| Bioinformatics prediction and luciferase reporter assay
The complementary sequence between TRAF6 3′UTR and miR 
| Western blot analysis
| Statistical analysis
All the data analyses were performed in the GraphPad Prism Version 6.0 software (GraphPad Prism Software, La Jolla, USA).
All the experimental assays were performed in triplicates. The data were shown as mean ± SD. Student's t test or one-way ANOVA followed by Turkey's post hoc test was used to analyse the statistical significance between different treatment groups.
The differences were considered to be statistically significant when P < 0.05. expression in both THP-1 and U937 cells in time-and concentration-dependent manners ( Figure 1B-1E ). In the sequent in vitro studies, M tb at 10 MOI infecting the macrophages for a duration of 48 hours was used.
| RE SULTS
| MiR-140 promoted M tb survival in macrophages
In Figure 3A-D) . Consistently, infection of M tb enhanced the mRNA expression of these pro-inflammatory cytokines in U937 cells ( Figure 3E-H) . Moreover, ELISA assay was performed to determine the protein levels of these pro-inflammatory cytokines, and M tb infection significantly caused the increase in protein levels of these pro-inflammatory cytokines in both THP-1 and U937 cells (Table 1) . (Table 2) .
| Effects of miR-
| MiR-140 suppressed TRAF6 expression via targeting the 3'UTR
To further explore the mechanisms of miR-140 in regulating the inflammatory responses, we performed bioinformatics analysis using Targetscan (www.targe tscan.org) prediction software.
There are many potential targets were predicted, and TRAF6 was selected from these predicted targets for further validation, as TRAF6 has been reported for its role in M tb infection. 20 The bioinformatics analysis showed that TRAF6 was one of the miR-140-targeted genes, and the complementary sequences between miR-140 and TRAF6 3′UTR were shown in Figure 5A . Furthermore, Neither miR-140 overexpression nor miR-140 knockdown affected the luciferase activity of mutant TRAF6 3′UTR-luciferase reporter vector in HEK293T cells ( Figure 5C ). 
| Effects of TRAF6 overexpression on miR-140-mediated pro-inflammatory cytokines expression in M tb-infected THP-1 and U937 cells
TA B L E 1 Effects of Mycobacterium tuberculosis (M tb) infection on the pro-inflammatory cytokines levels in macrophages
| D ISCUSS I ON
A growing evidence has implicated the importance of miRNAs for its functional role in TB infection. In the present investigation, Abbreviation: IFN-γ, interferon-γ; IL-6, interleukin 6; IL-1β, interleukin-1β; TNF-α, tumour necrosis-α; NC, negative control. *P < 0.05, **P < 0.01, ***P < 0.001 relative to mimic NC group; # P < 0.05, ## P < 0.01 relative to inhibitor NC group. All in all, these data showed that miR-140 modulated immune responses of macrophages to M tb infection partially via targeting TRAF6.
TA B L E 2 Effects of miR-140 on the pro-inflammatory cytokines levels in
There are several limitations in the current investigations.
Firstly, the miR-140 expression was only investigated in the isolated PBMCs from TB patients, and the determination of miR-140 expression levels in the sputum from TB patients may provide more solid evidence for the role of miR-140 in TB. Secondly, because of the difficulties in accessing the clinical features of the TB patients, whether miR-140 correlated with the clinical features of the TB patients and whether its expression in PBMCs was returned to the levels similar to the healthy volunteers should be determined in the further studies. Thirdly, our study mainly focused on the in vitro functional assays, and future studies may employ in vivo studies to confirm the role of miR-140 in TB, and performing mice infection experiments followed by quantification of miR-140 levels and pro-inflammatory cytokines would be more supportive for our current findings. Fourthly, the downstream targets of miR-140 were not limited to TRAF6, and it is necessary for us to further explore other interaction between miR-140 and other targets in the future studies. In addition, future work to confirm the findings in primary human monocyte-derived macrophages will be warranted.
| CON CLUS IONS
In conclusion, we demonstrated that up-regulation of miR-140
was detected in the human PBMCs from the TB patient, and the up-regulation of miR-140 was also found in the human macrophages upon M tb infection. Further in vitro mechanistic studies indicated that miR-140 promoted M tb survival and suppressed pro-inflammatory cytokines production in M tb-infected macrophages partially via modulating TRAF6 expression. 
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